Scott Schoenhaus
Stock Analyst at Keybanc
(2.14)
# 2,878
Out of 4,944 analysts
112
Total ratings
39.8%
Success rate
-4.69%
Average return
Main Sectors:
Stocks Rated by Scott Schoenhaus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LFMD LifeMD | Maintains: Overweight | $14 → $12 | $6.89 | +74.17% | 4 | Aug 6, 2025 | |
| SLP Simulations Plus | Downgrades: Sector Weight | n/a | $14.53 | - | 5 | Jul 15, 2025 | |
| HNGE Hinge Health | Maintains: Overweight | $45 → $60 | $58.05 | +3.36% | 2 | Jul 14, 2025 | |
| EMN Eastman Chemical Company | Maintains: Overweight | $106 → $93 | $66.55 | +39.74% | 1 | Jul 14, 2025 | |
| DOCS Doximity | Maintains: Overweight | $65 → $70 | $64.02 | +9.34% | 4 | Jul 14, 2025 | |
| CERT Certara | Maintains: Overweight | $18 → $15 | $11.17 | +34.29% | 5 | Jul 14, 2025 | |
| ALB Albemarle | Maintains: Overweight | $95 → $87 | $81.67 | +6.53% | 1 | Jul 14, 2025 | |
| ABCL AbCellera Biologics | Maintains: Overweight | $5 → $10 | $4.58 | +118.34% | 6 | Jul 14, 2025 | |
| SDGR Schrödinger | Maintains: Overweight | $30 → $32 | $19.84 | +61.29% | 5 | Apr 16, 2025 | |
| PHR Phreesia | Maintains: Overweight | $30 → $28 | $28.65 | -2.27% | 7 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $52 → $50 | $59.41 | -15.84% | 3 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $89.27 | +12.02% | 5 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $3.22 | +55.28% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $5 → $9 | $3.12 | +188.46% | 6 | Apr 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $285 → $255 | $279.18 | -8.66% | 15 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $12 → $10 | $5.70 | +75.44% | 6 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $6 | $3.56 | +68.54% | 5 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $4.5 | $2.58 | +74.42% | 1 | Dec 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $10 → $11 | $3.88 | +183.51% | 6 | Nov 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $23.06 | - | 5 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $31.35 | - | 8 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $7.44 | - | 4 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $180 → $250 | $190.23 | +31.42% | 2 | Apr 16, 2021 |
LifeMD
Aug 6, 2025
Maintains: Overweight
Price Target: $14 → $12
Current: $6.89
Upside: +74.17%
Simulations Plus
Jul 15, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $14.53
Upside: -
Hinge Health
Jul 14, 2025
Maintains: Overweight
Price Target: $45 → $60
Current: $58.05
Upside: +3.36%
Eastman Chemical Company
Jul 14, 2025
Maintains: Overweight
Price Target: $106 → $93
Current: $66.55
Upside: +39.74%
Doximity
Jul 14, 2025
Maintains: Overweight
Price Target: $65 → $70
Current: $64.02
Upside: +9.34%
Certara
Jul 14, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $11.17
Upside: +34.29%
Albemarle
Jul 14, 2025
Maintains: Overweight
Price Target: $95 → $87
Current: $81.67
Upside: +6.53%
AbCellera Biologics
Jul 14, 2025
Maintains: Overweight
Price Target: $5 → $10
Current: $4.58
Upside: +118.34%
Schrödinger
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $32
Current: $19.84
Upside: +61.29%
Phreesia
Apr 16, 2025
Maintains: Overweight
Price Target: $30 → $28
Current: $28.65
Upside: -2.27%
Apr 16, 2025
Maintains: Overweight
Price Target: $52 → $50
Current: $59.41
Upside: -15.84%
Apr 16, 2025
Maintains: Overweight
Price Target: $110 → $100
Current: $89.27
Upside: +12.02%
Apr 16, 2025
Maintains: Overweight
Price Target: $7 → $5
Current: $3.22
Upside: +55.28%
Apr 16, 2025
Maintains: Overweight
Price Target: $5 → $9
Current: $3.12
Upside: +188.46%
Jan 8, 2025
Maintains: Overweight
Price Target: $285 → $255
Current: $279.18
Upside: -8.66%
Jan 8, 2025
Maintains: Overweight
Price Target: $12 → $10
Current: $5.70
Upside: +75.44%
Jan 8, 2025
Maintains: Overweight
Price Target: $7 → $6
Current: $3.56
Upside: +68.54%
Dec 9, 2024
Initiates: Overweight
Price Target: $4.5
Current: $2.58
Upside: +74.42%
Nov 13, 2024
Maintains: Overweight
Price Target: $10 → $11
Current: $3.88
Upside: +183.51%
May 10, 2024
Downgrades: Sector Weight
Price Target: n/a
Current: $23.06
Upside: -
Oct 11, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $31.35
Upside: -
Sep 16, 2022
Initiates: Sector Weight
Price Target: n/a
Current: $7.44
Upside: -
Apr 16, 2021
Upgrades: Overweight
Price Target: $180 → $250
Current: $190.23
Upside: +31.42%